Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Oct 04, 2018 7:00am EDT

Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator

Aug 29, 2018 7:00am EDT

Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City

Aug 14, 2018 7:30am EDT

Heat Biologics Reports Second Quarter 2018 Results and Provides Corporate Update

May 30, 2018 7:00am EDT

Heat Biologics to Present at the 2018 BIO International Convention

May 15, 2018 7:00am EDT

Heat Biologics Reports First Quarter 2018 Results and Provides Corporate Update

May 07, 2018 5:10pm EDT

Heat Biologics, Inc. Announces Closing of $20.7 Million Public Offering

May 03, 2018 8:30am EDT

Heat Biologics, Inc. Prices $18,000,000 Public Offering

Apr 18, 2018 7:00am EDT

Heat Biologics Announces Upcoming Milestones Following Positive Interim Phase 2 Results for HS-110

Mar 26, 2018 7:00am EDT

Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform

Mar 19, 2018 6:00am EDT

Heat Biologics and Its Pelican Therapeutics Subsidiary Appoint Anthony Tolcher, M.D., FRCPC, FACP to their Scientific Advisory Boards

rss_feed News RSS